Page 1,704«..1020..1,7031,7041,7051,706..1,7101,720..»

stem cell research | Michigan Radio

Posted: October 6, 2016 at 7:46 am

Governor Rick Snyder says he is opposed to provisions in Republican budget plans that would restrict how money is spent on embryonic stem cell research at public universities.

Republican lawmakers are renewing efforts to enact additional rules surrounding the voter-approved amendment that allows public funds to be used for the research.

Voters approved the amendment to the state constitution in 2008.

Since then, Democrats have blocked efforts by opponents of embryonic stem cell research to demand reports or enact additional restrictions on it, but now Republicans are in charge in the Legislature.

Governor Snyder is a Republican who supports the voter-approved amendment and stem cell research.

The governor says he wishes Republican lawmakers would leave stem cell research out of the debates on university spending:

"I think we need to focus on higher education, not stem cells. We passed a constitutional amendment on that topic some time ago and we need to follow through on what our voters said."

The governor has the authority to veto budget line items.

The governor and the Legislature are continuing to negotiate on the budget with the goal of having it wrapped up by June first.

Read more from the original source:
stem cell research | Michigan Radio

Posted in Michigan Stem Cells | Comments Off on stem cell research | Michigan Radio

8th European Immunology Conference June 29-July 01, 2017 …

Posted: October 4, 2016 at 8:43 pm

Conference Series invites all the participants from all over the world to attend"8th European Immunology Conference, June 29-July 01, 2017 Madrid, Spain, includesprompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

European ImmunologyConferenceis to gathering people in academia and society interested inimmunologyto share the latest trends and important issues relevant to our field/subject area.Immunology Conferencesbrings together the global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. TheImmunology Conferencehosting presentations from editors of prominent refereed journals, renowned and active investigators and decision makers in the field of Immunology.European Immunology ConferenceOrganizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Track:1Cellular Immunology

The study of the molecular and cellular components that comprise the immune system, including their function and interaction, is the central science ofimmunology. The immune system has been divided into a more primitive innate immune system and, in vertebrates, an acquired oradaptive immune system

The field concerning the interactions among cells and molecules of the immunesystem,and how such interactions contribute to the recognition and elimination of pathogens. Humans possess a range of non-specific mechanical and biochemical defences against routinely encountered bacteria, parasites, viruses, and fungi. The skin, for example, is an effective physical barrier to infection. Basic chemical defences are also present in blood, saliva, and tears, and on mucous membranes. True protection stems from the host's ability to mount responses targeted to specific organisms, and to retain a form of memory that results in a rapid, efficient response to a given organism upon a repeat encounter. This more formal sense of immunity, termed adaptive immunity, depends upon the coordinated activities of cells and molecules of the immune system.

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

9thworld congress & expo on Immunology, Oct 02-04, 2017, Toronto, Canada; 3rdAntibodies and Bio Therapeutics Congress, November 02-03, 2017 Las Vegas, USA; Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 3rd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 2nd Autoimmunity Conference, Nov 9-10, 2017 Madrid, Spain; Integrating Metabolism and Immunity , May 29 - June 2, 2017 | Dublin, Ireland

Track: 2Inflammatory/Autoimmune Diseases

Autoimmune diseasescan affect almost any part of the body, including the heart, brain, nerves, muscles, skin, eyes, joints, lungs, kidneys, glands, the digestive tract, and blood vessels.

The classic sign of an autoimmune disease is inflammation, which can cause redness, heat, pain, and swelling. How an autoimmune disease affects you depends on what part of the body is targeted. If the disease affects the joints, as inrheumatoid arthritis, you might have joint pain, stiffness, and loss of function. If it affects the thyroid, as in Graves disease and thyroiditis, it might cause tiredness, weight gain, and muscle aches. If it attacks the skin, as it does in scleroderma/systemic sclerosis, vitiligo, andsystemic lupus erythematosus(SLE), it can cause rashes, blisters, and colour changes. Many autoimmune diseases dont restrict themselves to one part of the body. For example, SLE can affect the skin, joints, kidneys, heart, nerves, blood vessels, and more. Type 1 diabetes can affect your glands, eyes, kidneys, muscles, and more.

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

9thworld congress & expo on Immunology, Oct 02-04, 2017, Toronto, Canada; 3rdAntibodies and Bio Therapeutics Congress, November 02-03, 2017 Las Vegas, USA; Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; 3nd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 18th International Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; British Society for Immunology Congress, Dec 06-09, 2016, Liverpool, United Kingdom; 7thInternational Conference on Allergy, Asthma and Clinical Immunology

Track: 3T-Cells and B-Cells

T cell: A type of white blood cell that is of key importance to the immune system and is at the core of adaptive immunity, the system that tailors the body's immune response to specific pathogens. The T cells are like soldiers who search out and destroy the targeted invaders. Immature T cells (termed T-stem cells) migrate to the thymus gland in the neck, where they mature and differentiate into various types of mature T cells and become active in the immune system in response to a hormone called thymosin and other factors. T-cells that are potentially activated against the body's own tissues are normally killed or changed ("down-regulated") during this maturational process.There are several different types of mature T cells. Not all of their functions are known. T cells can produce substances called cytokines such as the interleukins which further stimulate the immune response. T-cell activation is measured as a way to assess the health of patients withHIV/AIDSand less frequently in other disorders. T cell are also known as T lymphocytes. The "T" stands for "thymus" -- the organ in which these cells mature. As opposed to B cells which mature in the bone marrow.B cells, also known asBlymphocytes, are a type of white bloodcellof the lymphocyte subtype. They function in thehumoral immunitycomponent of the adaptive immune system by secreting antibodies. Many B cells mature into what are called plasma cells that produce antibodies (proteins) necessary to fight off infections while other B cells mature into memory B cells. All of the plasma cells descended from a single B cell produce the same antibody which is directed against the antigen that stimulated it to mature. The same principle holds with memory B cells. Thus, all of the plasma cells and memory cells "remember" the stimulus that led to their formation. The maturation of B cells takes place in birds in an organ called the bursa of Fabricus. B cells in mammals mature largely in the bone marrow. The B cell, or B lymphocyte, is thus an immunologically important cell. It is not thymus-dependent, has a short lifespan, and is responsible for the production ofimmunoglobulins.It expresses immunoglobulins on its surface.

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; 3nd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 18thInternational Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 19thInternational Conference on Immunology (ICI) Sept 14-17, 2017, Berlin, Germany; Modelling Viral Infections and Immunity (E1) , May 1 - 4, 2017 | Estes Park, Colorado, USA; 7thInternational Conference on Allergy, Asthma and Clinical Immunology

Track: 4Cancer and Tumor Immunobiology

The tumour is an important aspect of cancer biology that contributes to tumour initiation, tumour progression and responses to therapy. Cells and molecules of the immune system are a fundamental component of the tumour microenvironment. Importantly,therapeutic strategies for cancer treatmentcan harness the immune system to specifically target tumour cells and this is particularly appealing owing to the possibility of inducing tumour-specific immunological memory, which might cause long-lasting regression and prevent relapse in cancer patients.The composition and characteristics of the tumour microenvironment vary widely and are important in determining the anti-tumour immune response.Immunotherapyis a new class ofcancer treatmentthat works to harness the innate powers of the immune system to fight cancer. Because of the immune system's unique properties, these therapies may hold greater potential than current treatment approaches to fight cancer more powerfully, to offer longer-term protection against the disease, to come with fewer side effects, and to benefit more patients with more cancer

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

9thworld congress & expo on Immunology, Oct 02-04, 2017, Toronto, Canada; 3rdAntibodies and Bio Therapeutics Congress, November 02-03, 2017 Las Vegas, USA; Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; 3nd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 18th International Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; British Society for Immunology Congress, Dec 06-09, 2016, Liverpool, United Kingdom; 7thInternational Conference on Allergy, Asthma and Clinical Immunology

Track: 5 Vaccines

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. There are two basictypes of vaccines: live attenuated and inactivated. The characteristics of live and inactivatedvaccinesare different, and these characteristics determine how thevaccineis used. Liveattenuatedvaccinesare produced by modifying a disease-producing (wild) virus or bacteria in a laboratory.

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; 3nd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 18thInternational Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 19thInternational Conference on Immunology (ICI) Sept 14-17, 2017, Berlin, Germany; Modelling Viral Infections and Immunity (E1) , May 1 - 4, 2017 | Estes Park, Colorado, USA; 7thInternational Conference on Allergy, Asthma and Clinical Immunology

Track: 6Immunotherapy

Immunotherapy,also called biologic therapy, is a type of cancer treatment designed to boost the body's natural defences to fight the cancer. It uses materials either made by the body or in a laboratory to improve, target, or restore immune system function. Immunotherapy is treatment that uses certain parts of a persons immune system to fight diseases such as cancer. This can be done in a couple of ways:1)Stimulating your own immune system to work harder or smarter to attack cancer cells2)Giving you immune system components, such as man-made immune system proteins. Some types of immunotherapy are also sometimes called biologic therapy or biotherapy.

In the last few decadesimmunotherapyhas become an important part of treating some types of cancer. Newer types of immune treatments are now being studied, and theyll impact how we treat cancer in the future. Immunotherapy includes treatments that work in different ways. Some boost the bodys immune system in a very general way. Others help train the immune system to attack cancer cells specifically. Immunotherapy works better for some types of cancer than for others. Its used by itself for some of these cancers, but for others it seems to work better when used with other types of treatment.

Many different types of immunotherapy are used to treat cancer. They include:Monoclonal antibodies,Adoptive cell transfer,Cytokines, Treatment Vaccines, BCG,

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

9thworld congress & expo on Immunology, Oct 02-04, 2017, Toronto, Canada; 3rdAntibodies and Bio Therapeutics Congress, November 02-03, 2017 Las Vegas, USA; Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 3rd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 2nd Autoimmunity Conference, Nov 9-10, 2017 Madrid, Spain; Integrating Metabolism and Immunity , May 29 - June 2, 2017 | Dublin, Ireland; American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, March 03-06, 2017, Atlanta, Georgia

Track: 7Neuro Immunology

Neuroimmunology, a branch of immunologythat deals especially with the inter relationships of the nervous system and immune responses andautoimmune disorders. It deals with particularly fundamental and appliedneurobiology,meetings onneurology,neuropathology, neurochemistry,neurovirology, neuroendocrinology, neuromuscular research,neuropharmacologyand psychology, which involve either immunologic methodology (e.g. immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays).

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; 3nd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 18thInternational Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 19thInternational Conference on Immunology (ICI) Sept 14-17, 2017, Berlin, Germany; Modelling Viral Infections and Immunity (E1) , May 1 - 4, 2017 | Estes Park, Colorado, USA; 7thInternational Conference on Allergy, Asthma and Clinical Immunology; 18thInternational Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand

Track: 8Infectious Diseases and Immune System

Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from one person to another.Zoonotic diseasesare infectious diseases of animals that can cause disease when transmitted to humans. Some infectious diseases can be passed from person to person. Some are transmitted by bites from insects or animals. And others are acquired by ingesting contaminated food or water or being exposed to organisms in the environment. Signs and symptoms vary depending on the organism causing the infection, but often include fever and fatigue. Mild complaints may respond to rest and home remedies, while some life-threatening infections may require hospitalization.

Many infectious diseases, such as measles andchickenpox, can be prevented by vaccines. Frequent and thorough hand-washing also helps protect you from infectious diseases

There are four main kinds of germs:

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; 3nd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 18thInternational Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 19thInternational Conference on Immunology (ICI) Sept 14-17, 2017, Berlin, Germany; Modelling Viral Infections and Immunity (E1) , May 1 - 4, 2017 | Estes Park, Colorado, USA; 7thInternational Conference on Allergy, Asthma and Clinical Immunology; 18thInternational Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand

Track: 9Reproductive Immunology,

Reproductive immunologyrefers to a field of medicine that studies interactions (or the absence of them) between the immune system and components related to thereproductivesystem, such as maternal immune tolerance towards the fetus, orimmunologicalinteractions across the blood-testis barrier. The immune system refers to all parts of the body that work to defend it against harmful enemies. In people with immunological fertility problems their body identifies part of reproductive function as an enemy and sendsNatural Killer (NK) cellsto attack. A healthy immune response would only identify an enemy correctly and attack only foreign invaders such as a virus, parasite, bacteria, ect.

The concept of reproductive immunology is not widely accepted by all physicians.Those patients who have had repeated miscarriages and multiple failed IVF's find themselves exploring it's possibilities as the reason. With an increased amount of success among treating any potential immunological factors, the idea of reproductive immunology can no longer be overlooked.The failure to conceive is often due to immunologic problems that can lead to very early rejection of the embryo, often before the pregnancy can be detected by even the most sensitive tests. Women can often produce perfectly healthy embryos that are lost through repeated "mini miscarriages." This most commonly occurs in women who have conditions such asendometriosis, an under-active thyroid gland or in cases of so called "unexplained infertility." It has been estimated that an immune factor may be involved in up to 20% of couples with otherwiseunexplained infertility. These are all conditions where abnormalities of the womans immune system may play an important role.

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

9thworld congress & expo on Immunology, Oct 02-04, 2017, Toronto, Canada; 3rdAntibodies and Bio Therapeutics Congress, November 02-03, 2017 Las Vegas, USA; Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; 3nd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 18th International Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; British Society for Immunology Congress, Dec 06-09, 2016, Liverpool, United Kingdom; 7thInternational Conference on Allergy, Asthma and Clinical Immunology; Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology (C7), March 19 - 23, 2017, Whistler, British Columbia, Canada

Track:10Auto Immunity,

Autoimmunityis the system ofimmuneresponses of an organism against its own cells and tissues. Any disease that results from such an aberrantimmuneresponse is termed an autoimmune disease.

Autoimmunity is present to some extent in everyone and is usually harmless. However, autoimmunity can cause a broad range of human illnesses, known collectively as autoimmune diseases. Autoimmune diseases occur when there is progression from benign autoimmunity to pathogenicautoimmunity. This progression is determined by genetic influences as well as environmental triggers. Autoimmunity is evidenced by the presence of autoantibodies (antibodies directed against the person who produced them) and T cells that are reactive with host antigens.

Autoimmune disorders

An autoimmune disorder occurs whenthe bodys immune systemattacks and destroys healthy body tissue by mistake. There are more than 80 types of autoimmune disorders.

Causes

The white blood cells in the bodys immune system help protect against harmful substances. Examples include bacteria, viruses,toxins,cancercells, and blood and tissue from outside the body. These substances contain antigens. The immune system producesantibodiesagainst these antigens that enable it to destroy these harmful substances. When you have an autoimmune disorder, your immune system does not distinguish between healthy tissue and antigens. As a result, the body sets off a reaction that destroys normal tissues. The exact cause of autoimmune disorders is unknown. One theory is that some microorganisms (such as bacteria or viruses) or drugs may trigger changes that confuse the immune system. This may happen more often in people who have genes that make them more prone toautoimmune disorders.

An autoimmune disorder may result in:

A person may have more than one autoimmune disorder at the same time. Common autoimmune disorders include:

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

9thworld congress & expo on Immunology, Oct 02-04, 2017, Toronto, Canada; 3rdAntibodies and Bio Therapeutics Congress, November 02-03, 2017 Las Vegas, USA; Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; 3nd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 18th International Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; British Society for Immunology Congress, Dec 06-09, 2016, Liverpool, United Kingdom; 7thInternational Conference on Allergy, Asthma and Clinical Immunology; Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology (C7), March 19 - 23, 2017, Whistler, British Columbia, Canada

Track: 11Costimmulatory pathways in multiple sclerosis

Costimulatory moleculescan be categorized based either on their functional attributes or on their structure. The costimulatory molecules discussed in this review will be divided into (1)positive costimulatory pathways:promoting T cell activation, survival and/or differentiation; (2)negative costimulatory pathways:antagonizing TCR signalling and suppressing T cell activation; (3) as third group we will discuss themembers of the TIM family, a rather new family of cell surface molecules involved in the regulation of T cell differentiation and Treg function.Costimulatory pathways have a critical role in the regulation of alloreactivity. A complex network of positive and negative pathways regulates T cell responses. Blocking costimulation improves allograft survival in rodents and non-human primates. The costimulation blocker belatacept is being developed asimmunosuppressivedruginrenal transplantation.

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

3rdAntibodies and Bio Therapeutics Congress, November 02-03, 2017 Las Vegas, USA; Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 3rd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 2nd Autoimmunity Conference, Nov 9-10, 2017 Madrid, Spain; Integrating Metabolism and Immunity , May 29 - June 2, 2017 | Dublin, Ireland; American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, March 03-06, 2017, Atlanta, Georgia

Track: 12Autoimmunity and Therapathies

Autoimmunityis the system ofimmuneresponsesof an organism against its own cells and tissues. Any disease that results from such an aberrantimmuneresponse is termed an autoimmune disease.

Autoimmunity is present to some extent in everyone and is usually harmless. However, autoimmunity can cause a broad range of human illnesses, known collectively as autoimmune diseases.Autoimmune diseasesoccur when there is progression from benign autoimmunity to pathogenic autoimmunity. This progression is determined by genetic influences as well as environmental triggers. Autoimmunity is evidenced by the presence of autoantibodies (antibodies directed against the person who produced them) and T cells that are reactive with host antigens.

Current treatments for allergic and autoimmune disease treat disease symptoms or depend on non-specific immune suppression. Treatment would be improved greatly by targeting the fundamental cause of the disease, that is the loss of tolerance to an otherwise innocuous antigen in allergy or self-antigen in autoimmune disease (AID). Much has been learned about the mechanisms of peripheral tolerance in recent years. We now appreciate that antigen presenting cells (APC) may be either immunogenic or tolerogenic, depending on their location, environmental cues and activation state

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

3rdAntibodies and Bio Therapeutics Congress, November 02-03, 2017 Las Vegas, USA; Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 3rd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 2nd Autoimmunity Conference, Nov 9-10, 2017 Madrid, Spain; Integrating Metabolism and Immunity , May 29 - June 2, 2017 | Dublin, Ireland; American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, March 03-06, 2017, Atlanta, Georgia

Track: 13DiagnosticImmunology

Diagnostic Immunology. Immunoassays are laboratory techniques based on the detection of antibody production in response to foreign antigens. Antibodies, part of the humoral immune response, are involved in pathogen detection and neutralization.

Diagnostic immunology has considerably advanced due to the development of automated methods.New technology takes into account saving samples, reagents, and reducing cost.The future of diagnosticimmunologyfaces challenges in the vaccination field for protection against HIV and asanti-cancer therapy. Modern immunology relies heavily on the use of antibodies as highly specific laboratory reagents. The diagnosis of infectious diseases, the successful outcome of transfusions and transplantations, and the availability of biochemical and hematologic assays with extraordinary specificity and sensitivity capabilities all attest to the value of antibody detection.Immunologic methods are used in the treatment and prevention ofinfectious diseasesand in the large number of immune-mediated diseases. Advances in diagnostic immunology are largely driven by instrumentation, automation, and the implementation of less complex and more standardized procedures.

Examples of such processes are as follows:

These methods have facilitated the performance of tests and have greatly expanded the information that can be developed by a clinical laboratory. The tests are now used for clinical diagnosis and the monitoring of therapies and patient responses. Immunology is a relatively young science and there is still so much to discover. Immunologists work in many different disease areas today that include allergy, autoimmunity, immunodeficiency, transplantation, and cancer.

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

3nd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 18thInternational Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 19thInternational Conference on Immunology (ICI) Sept 14-17, 2017, Berlin, Germany; Modelling Viral Infections and Immunity (E1) , May 1 - 4, 2017 | Estes Park, Colorado, USA; 7thInternational Conference on Allergy, Asthma and Clinical Immunology; 18thInternational Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand

Track: 14Allergy and Therapathies

Although medications available for allergy are usually very effective, they do not cure people of allergies. Allergenimmunotherapyis the closest thing we have for a "cure" for allergy, reducing the severity of symptoms and the need for medication for many allergy sufferers. Allergen immunotherapy involves the regular administration of gradually increasing doses of allergen extracts over a period of years. Immunotherapy can be given to patients as an injection or as drops or tablets under the tongue (sublingual).Allergen immunotherapy changes the way the immune system reacts to allergens, by switching off allergy. The end result is that you become immune to the allergens, so that you can tolerate them with fewer or no symptoms. Allergen immunotherapy is not, however, a quick fix form of treatment. Those agreeing to allergen immunotherapy need to be committed to 3-5 years of treatment for it to work, and to cooperate with your doctor to minimize the frequency of side effects.Allergen immunotherapyis usually recommended for the treatment of potentially life threatening allergic reactions to stinging insects. Published data on allergen immunotherapy injections shows that venom immunotherapy can reduce the risk of a severe reaction in adults from around 60 % per sting, down to less than 10%. In Australia and New Zealand,venom immunotherapyis currently available for bee and wasp allergy. Jack Jumper Ant immunotherapy is available in Tasmania for Tasmanian residents. Allergen immunotherapy is often recommended for treatment ofallergic rhinitis

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; 3nd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 18thInternational Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 19thInternational Conference on Immunology (ICI) Sept 14-17, 2017, Berlin, Germany; Modelling Viral Infections and Immunity (E1) , May 1 - 4, 2017 | Estes Park, Colorado, USA; 7thInternational Conference on Allergy, Asthma and Clinical Immunology; 18thInternational Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand

Track: 15Technological Innovations inImmunology

Immunology is the branch of biomedical sciences concerned with all aspects of the immune system in all multicellular organisms. Immunology deals with physiological functioning of the immune system in states of both health and disease as well as malfunctions of the immune system in immunological disorders like allergies, hypersensitivities, immune deficiency, transplant rejection andautoimmune disorders.

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

9thworld congress & expo on Immunology, Oct 02-04, 2017, Toronto, Canada; 3rdAntibodies and Bio Therapeutics Congress, November 02-03, 2017 Las Vegas, USA; Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 3rd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 2nd Autoimmunity Conference, Nov 9-10, 2017 Madrid, Spain; Integrating Metabolism and Immunity , May 29 - June 2, 2017 | Dublin, Ireland; American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, March 03-06, 2017, Atlanta, Georgia

Track:16Antigen Processing

Antigen processingis an immunologicalprocessthat prepares antigensfor presentation to special cells of the immune system called T lymphocytes. It is considered to be a stage ofantigenpresentation pathways. The process by which antigen-presenting cells digest proteins from inside or outside the cell and display the resulting antigenic peptide fragments on cell surface MHC molecules for recognition by T cells is central to the body's ability to detect signs of infection or abnormal cell growth. As such, understanding the processes and mechanisms of antigen processing and presentation provides us with crucial insights necessary for the design ofvaccines and therapeutic strategiesto bolster T-cell responses.

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

3rdAntibodies and Bio Therapeutics Congress, November 02-03, 2017 Las Vegas, USA; Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 3rd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 2nd Autoimmunity Conference, Nov 9-10, 2017 Madrid, Spain; Integrating Metabolism and Immunity , May 29 - June 2, 2017 | Dublin, Ireland; American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, March 03-06, 2017, Atlanta, Georgia

Track: 17Immunoinformatics and Systems Immunology

Immunoinformaticsis a branch ofbioinformaticsdealing with in silico analysis and modelling of immunological data and problems Immunoinformatics includes the study and design of algorithms for mapping potential B- andT-cell epitopes, which lessens the time and cost required for laboratory analysis of pathogen gene products. Using this information, an immunologist can explore the potential binding sites, which, in turn, leads to the development of newvaccines. This methodology is termed reversevaccinology and it analyses the pathogen genome to identify potential antigenic proteins.This is advantageous because conventional methods need to cultivate pathogen and then extract its antigenic proteins. Although pathogens grow fast, extraction of their proteins and then testing of those proteins on a large scale is expensive and time consuming. Immunoinformatics is capable of identifying virulence genes and surface-associated proteins.

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

9thworld congress & expo on Immunology, Oct 02-04, 2017, Toronto, Canada; 3rdAntibodies and Bio Therapeutics Congress, November 02-03, 2017 Las Vegas, USA; Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; 3nd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 18th International Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; British Society for Immunology Congress, Dec 06-09, 2016, Liverpool, United Kingdom; 7thInternational Conference on Allergy, Asthma and Clinical Immunology; Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology (C7), March 19 - 23, 2017, Whistler, British Columbia, Canada

Track: 18Rheumatology

Rheumatology represents a subspecialty in internal medicine and pediatrics, which is devoted to adequate diagnosis andtherapy of rheumatic diseases(including clinical problems in joints, soft tissues, heritable connective tissue disorders, vasculitis and autoimmune diseases). This field is multidisciplinary in nature, which means it relies on close relationships with other medical specialties.The specialty of rheumatology has undergone a myriad of noteworthy advances in recent years, especially if we consider the development of state-of-the-art biological drugs with novel targets, made possible by rapid advances in the basic science of musculoskeletal diseases and improved imaging techniques.

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

Molecular Immunology & Immunogenetics Congress, March 20-21, 2017 Rome, Italy; 3nd International Congress on Neuroimmunology and Therapeutics, September 18-19, 2017 Philadelphia, USA; 18thInternational Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 19thInternational Conference on Immunology (ICI) Sept 14-17, 2017, Berlin, Germany; Modelling Viral Infections and Immunity (E1) , May 1 - 4, 2017 | Estes Park, Colorado, USA; 7thInternational Conference on Allergy, Asthma and Clinical Immunology; 18thInternational Conference on Immunology (ICI) Dec 12-13, 2016, Bangkok, Thailand

Track: 19Nutritional Immunology

Nutritional immunologyis an emerging discipline that evolved with the study of the detrimental effect of malnutrition on the immune system. The clinical and public health importance of nutritional immunology is also receiving attention. Immune system dysfunctions that result from malnutrition are, in fact, NutritionallyAcquired Immune Deficiency Syndromes(NAIDS). NAIDS afflicts millions of people in the Third World, as well as thousands in modern centers, i.e., patients with cachexia secondary to serious disease, neoplasia or trauma. The human immune system functions to protect the body against foreign pathogens and thereby preventing infection and disease. Optimal functioning of the immune system, both innate and adaptive immunity, is strongly influenced by an individuals nutritional status, with malnutrition being the most common cause of immunodeficiency in the world. Nutrient deficiencies result in immunosuppression and dysregulation of the immune response including impairment of phagocyte function and cytokine production, as well as adversely affecting aspects of humoral and cell-mediated immunity. Such alterations in immune function and the resulting inflammation are not only associated with infection, but also with the development of chronic diseases including cancer, autoimmune disease, osteoporosis, disorders of the endocrine system andcardiovascular disease.

RelatedImmunology Conferences|Immunologists Meetings|Conference Series LLC:

See more here:
8th European Immunology Conference June 29-July 01, 2017 ...

Posted in Colorado Stem Cells | Comments Off on 8th European Immunology Conference June 29-July 01, 2017 …

Top 10 biotech companies and Top 100 biotechnology places …

Posted: October 3, 2016 at 8:43 am

Top 10 biotech companies in India 1. Biocon Established in the year 1978 Biocon, global biopharmaceutical enterprise is actively involved in the manufacturing and development of innovative technologies that includes large-scale chemical synthesis, microbial fermentation, mammalian cell culture, purification of protein & antibody and various aseptic formulations. Chairman Kiran Mazumdar-Shaw; Corporate Office Bangalore, India | Sector Private | Website http://www.biocon.com 2. Serum Institute of India Serum Institute of India Ltd. established in the year 1966 is the world's largest producer of Measles and DTP group of vaccines. The company manufactures life-saving Biologicals including Anti-Snake Venom and Tetanus Antitoxin serum, DTP (Diphtheria, Tetanus and Pertussis) and MMR (Measles, Mumps and Rubella) group of vaccines at affordable prices. Chairman Cyrus S. Poonawalla; Location: Pune, India | Sector Private | Website http://www.seruminstitute.com 3. Panacea Biotech Ltd Panacea Biotec established in the year 1976, has strong R and D capabilities with a wide range of pipeline including: Development various complex pharmaceutical generic compounds Technologies) Development of New Chemical Entities (NCE) Vaccines Chairman Soshil Kumar, Corporate Office New Delhi, India | | Business Pharmaceutical, Biotechnology | Sector Private | Website http://www.panacea-biotec.com 4. Novo Nordisk Established in the year 1923, Novo Nordisk is the worlds leader in diabetes care, manufacturing broadest diabetes product that includes development of the most advanced products related to insulin delivery systems. Chairman Sten Scheibye, Corporate Office Denmark, Business -Sector Pharmaceutical- Private | Website http://www.novonordisk.co.in 5. GlaxoSmithKline Pharmaceuticals Ltd. One of the earliest pharmaceutical companies in India is GSK India. It was established in the year 1924. The GSK India is an important group of manufacturing products of wide range of prescription medicines and vaccines in therapeutic areas such as dermatology, anti-infectives, diabetes, oncology, cardiovascular and respiratory diseases. The company also manufactures vaccines for prevention of hepatitis A and B, invasive diseases caused by H. influenzae, chickenpox, DPT, cervical cancer, rotavirus, Streptococcal pneumonia etc. Chairman Chris Gent; Corporate Office London, United Kingdom Business Biotechnology and Pharmaceutical, Sector Private | Website http://www.gsk-india.com 6. SIRO Clinpharm Established in the year 1996 the company provides a wide range of services including Clinical Operations & Clinical Monitoring, Clinical Data management, medical and scientific writing, biostatistics and statistical programming, clinical trial supplies management, pharmacovigilance. Chairman Dr. Gautam Daftary; Corporate Office Thane, India | | | Business Drug Development; Sector Private | Website http://www.siroclinpharm.com 7. Novozymes, South Asia Novozymes a biotech company established in 1925 strongly focus on production of novel enzymes. The companys biosolution provides everything from the removal of trans fats in food to advancements in bioenergy sources. Chairman Kbenhavns Lufthavne; Corporate Office Bagsvaerd, Denmark; Novozymes South Asia Pvt. Ltd. Bangalore, India; Sector Private | Website http://www.novozymes.com 8. Zydus Cadila Zydus Cadila, established in the year 1952, is a fully integrated, global healthcare company with complete healthcare solutions ranging from active pharmaceutical ingredients, formulations products related to animal health care to wellness products. The company is the only Indian pharma establishment that launched the worlds first drug NCE Lipaglyn for treatment of diabetic dyslipidemia. Chairman - Mr. Pankaj R. Patel, Corporate office-Ahmedabad, Sector- Private Website- http://www.zyduscadila.com 9. Indian Immunologicals Indian Immunologicals Ltd. (IIL) was established in 1982 by The National Dairy Development Board (NDDB) with the focus to manufacture Foot and Mouth Disease (FMD) vaccine available to poor people at an affordable price. IIL provides a range of adult as well as child vaccines. Chairman Dr. Amrita Patel; Corporate Office Hyderabad, India Business-sector Biotechnology-private; Website http://www.indimmune.com 10. Wockhardt Ltd. Established in the year 1960 Wockhardt Ltd. is an international manufacturer of biopharmaceutical formulations along with Active Pharmaceutical Ingredients (API). An integrated multi-technology capability was developed by the company for manufacturing all types of dosage formulation that includes sterile injectables and lyophilised products. Chairman Habil Khorakiwala; Corporate Office Mumbai, India; Business Sector Biotechnology and Pharmaceutics-private Website http://www.wockhardt.com

More here:
Top 10 biotech companies and Top 100 biotechnology places ...

Posted in Biotechnology | Comments Off on Top 10 biotech companies and Top 100 biotechnology places …

epigenetics | Britannica.com

Posted: September 29, 2016 at 3:48 pm

Epigenetics, the study of the chemical modification of specific genes or gene-associated proteins of an organism. Epigenetic modifications can define how the information in genes is expressed and used by cells. The term epigenetics came into general use in the early 1940s, when British embryologist Conrad Waddington used it to describe the interactions between genes and gene products, which direct development and give rise to an organisms phenotype (observable characteristics). Since then, information revealed by epigenetics studies has revolutionized the fields of genetics and developmental biology. Specifically, researchers have uncovered a range of possible chemical modifications to deoxyribonucleic acid (DNA) and to proteins called histones that associate tightly with DNA in the nucleus. These modifications can determine when or even if a given gene is expressed in a cell or organism.

The principal type of epigenetic modification that is understood is methylation (addition of a methyl group). Methylation can be transient and can change rapidly during the life span of a cell or organism, or it can be essentially permanent once set early in the development of the embryo. Other largely permanent chemical modifications also play a role; these include histone acetylation (addition of an acetyl group), ubiquitination (the addition of a ubiquitin protein), and phosphorylation (the addition of a phosphoryl group). The specific location of a given chemical modification can also be important. For example, certain histone modifications distinguish actively expressed regions of the genome from regions that are not highly expressed. These modifications may correlate with chromosome banding patterns generated by staining procedures common in karyotype analyses. Similarly, specific histone modifications may distinguish actively expressed genes from genes that are poised for expression or genes that are repressed in different kinds of cells.

It is clear that at least some epigenetic modifications are heritable, passed from parents to offspring in a phenomenon that is generally referred to as epigenetic inheritance, or passed down through multiple generations via transgenerational epigenetic inheritance. The mechanism by which epigenetic information is inherited is unclear; however, it is known that this information, because it is not captured in the DNA sequence, is not passed on by the same mechanism as that used for typical genetic information. Typical genetic information is encoded in the sequences of nucleotides that make up the DNA; this information is therefore passed from generation to generation as faithfully as the DNA replication process is accurate. Many epigenetic modifications, in fact, are spontaneously erased or reset when cells reproduce (whether by meiosis or mitosis), thereby precluding their inheritance.

Epigenetic changes not only influence the expression of genes in plants and animals but also enable the differentiation of pluripotent stem cells (cells having the potential to become any of many different kinds of cells). In other words, epigenetic changes allow cells that all share the same DNA and are ultimately derived from one fertilized egg to become specializedfor example, as liver cells, brain cells, or skin cells.

As the mechanisms of epigenetics have become better understood, researchers have recognized that the epigenomechemical modification at the level of the genomealso influences a wide range of biomedical conditions. This new perception has opened the door to a deeper understanding of normal and abnormal biological processes and has offered the possibility of novel interventions that might prevent or ameliorate certain diseases.

Epigenetic contributions to disease fall into two classes. One class involves genes that are themselves regulated epigenetically, such as the imprinted (parent-specific) genes associated with Angelman syndrome or Prader-Willi syndrome. Clinical outcomes in cases of these syndromes depend on the degree to which an inherited normal or mutated gene is or is not expressed. The other class involves genes whose products participate in the epigenetic machinery and thereby regulate the expression of other genes. For example, the gene MECP2 (methyl CpG binding protein 2) encodes a protein that binds to specific methylated regions of DNA and contributes to the silencing of those sequences. Mutations that impair the MECP2 gene can lead to Rett syndrome.

Many tumours and cancers are believed to involve epigenetic changes attributable to environmental factors. These changes include a general decrease in methylation, which is thought to contribute to the increased expression of growth-promoting genes, punctuated by gene-specific increases in methylation that are thought to silence tumour-suppressor genes. Epigenetic signaling attributed to environmental factors has also been associated with some characteristics of aging by researchers that studied the apparently unequal aging rates in genetically identical twins.

Test Your Knowledge

Branches of Genetics

One of the most promising areas of epigenetic investigation involves stem cells. Researchers have understood for some time that epigenetic mechanisms play a key role in defining the potentiality of stem cells. As those mechanisms become clearer, it may become possible to intervene and effectively alter the developmental state and even the tissue type of given cells. The implications of this work for future clinical regenerative intervention for conditions ranging from trauma to neurodegenerative disease are profound.

...and the yeast Saccharomyces cerevisiae, as well as for numerous microorganisms. Additional research during this time explored alternative mechanisms of inheritance, including epigenetic modification (the chemical modification of specific genes or gene-associated proteins), that could explain an organisms ability to transmit traits developed during its lifetime to its...

The term epigenetic is used to describe the dynamic interplay between genes and the environment during the course of development. The study of epigenetics highlights the complex nature of the relationship between the organisms genetic code, or genome, and the organisms directly observable physical and psychological manifestations and behaviours. In contemporary use, the term refers to...

unit of hereditary information that occupies a fixed position (locus) on a chromosome. Genes achieve their effects by directing the synthesis of proteins.

Read more:
epigenetics | Britannica.com

Posted in Epigenetics | Comments Off on epigenetics | Britannica.com

Center for Stem Cell Biology | Memorial Sloan Kettering …

Posted: September 29, 2016 at 3:46 pm

New York State Stem Cell Science Consortia

Center for Stem Cell Biology investigators are leading a multidisciplinary effort to develop a cell based therapy for the treatment of Parkinsons disease.

The Center for Stem Cell Biology (CSCB) was established in 2010 to serve as a hub for existing stem cell efforts at Memorial Sloan Kettering Cancer Center. The center also supports targeted recruitment of stem cell faculty and provides resources for stem cell research such as core facilities and trainings programs.

Memorial Sloan Kettering has been a leader in various aspects of stem cell research for many years. It has been at the forefront of realizing the potential of hematopoietic stem cells in the treatment of hematopoietic malignancies, the use of umbilical cord blood as a source of stem cells suitable for transplantation, and the isolation of human mesenchymal stem cells. In recent years research has expanded to new areas such as neural stem cells, embryonic stem cells, and induced pluripotent stem cells. The CSCB will link these existing stem cell research efforts and build the resources critical for new developments in the future.

To achieve these goals the CSCB will bring together scientists across various programs with a broad range of expertise in the following areas: cancer pathogenesis, cell biology, chemical biology, computational biology, developmental biology, and pharmacology. These partnerships will facilitate research projects that transcend traditional departmental boundaries to explore the full potential of stem cells, ranging from basic developmental studies to the use of human stem cells in drug discovery. Another core mission of the CSCB is the training of investigators in stem cell technologies such as induced pluripotency, directed differentiation, genetic modification, and prospective purification of stem cells. Finally, the CSCB links stem cell efforts at Memorial Sloan Kettering with the Tri-Institutional Stem Cell Initiative, a collaborative program of Memorial Sloan Kettering, The Rockefeller University, and Weill Cornell Medical College, as well as with other national and international stem cell organizations.

The rest is here:
Center for Stem Cell Biology | Memorial Sloan Kettering ...

Posted in New York Stem Cells | Comments Off on Center for Stem Cell Biology | Memorial Sloan Kettering …

List of Biotechnology Colleges in Delhi

Posted: September 29, 2016 at 3:44 pm

Delhi College of Engineering

Profile:

Address: 14875, New Campus Shahbad, Warden Flat, Daulatpur, Engineering College New Delhi

Year Founded: 1941

Website: http://www.dce.edu

Profile:

Address: 4, Patel Marg,Maurice Nagar, Delhi

Year Founded: 1960

Profile:

Address: Ansari Nagar, New Delhi

Year Founded: 1956

Website: http://www.aiims.ac.in

Profile:

Address: Aruna Asaf Ali Marg, New Delhi

Website: www1.nii.res.in

Profile:

Address: Azad Hing Fauj Marg, Sector 3, Dwarka (Pappankalan), New Delhi

Year Founded: 1983

Website: http://www.nsit.ac.in

Profile:

Address: Benito Juarez Road,Dhaula Kuan, New Dehli

Year Founded: 1961

Website: http://www.svc.ac.in

Profile:

Address: F-4, Hauz Khas Enclave, Near Hauz Khas Metro Station, New Delhi

Year Founded: 1961

Website: http://www.ihe-du.com

Profile:

Address: Faculty of Natural Sciences,Jamia Millia Islamia,DELHI , New Delhi

Website: http://www.jmi.ac.in

Profile:

Address: Hamdard Nagar, New Delhi

Year Founded: 1906

Website: http://www.jamiahamdard.edu

Profile:

Address: Hauz Khas Safdarganj Development Area, Hauz Khas, New Delhi

Website: http://www.iitd.ac.in

Profile:

Address: Kalkaji, New Delhi

Website: http://www.deshbandhucollege.ac.in

Profile:

Address: Kashmere Gate, New Delhi

Website: http://www.ggsipu.nic.in

Profile:

Address: Main Campus, Karol Bagh, New Delhi, Delhi

Website: http://www.du.ac.in

Profile:

Address: National Highway 1 New Delhi

Year Founded: 1967

Website: http://www.ssncollege.com

Profile:

Facilities:

Address: New Mehrauli Road, New Delhi

Year Founded: 1970

Website: http://www.jnu.ac.in

Profile:

Facilities:

Address: Ring Road, Raja Garden,New Delhi

Year Founded: 1961

Website: http://www.shivajicollege.ac.in

Profile:

Address: RZ-A-44 Mahipalpur Ext., New Delhi

Year Founded: 1976

Website: http://www.iphhparamedic.in

Profile:

Address: V Floor, Anuvrat Bhawan, 210, Deen Dayal Upadhay Marg, New Delhi

Year Founded: 1990

Website: http://www.bcil.nic.in

Read this article:
List of Biotechnology Colleges in Delhi

Posted in Biotechnology | Comments Off on List of Biotechnology Colleges in Delhi

Molecular genetics – Wikipedia, the free encyclopedia

Posted: September 28, 2016 at 5:47 pm

Molecular genetics is the field of biology and genetics that studies the structure and function of genes at a molecular level. The study of chromosomes and gene expression of an organism can give insight into heredity, genetic variation, and mutations. This is useful in the study of developmental biology and in understanding and treating genetic diseases.

Gene amplification is a procedure in which a certain gene or DNA sequence is replicated many times in a process called DNA replication.

The recombinant DNA molecules are then put into a bacterial strain (usually E. coli) which produces several identical copies by transformation. Transformation is the DNA uptake mechanism possessed by bacteria. However, only one recombinant DNA molecule can be cloned within a single bacteria cell, so each clone is of just one DNA insert.

In separation and detection DNA and mRNA are isolated from cells and then detected simply by the isolation. Cell cultures are also grown to provide a constant supply of cells ready for isolation.

First, laboratories use a normal cellular modification of mRNA that adds up to 200 adenine nucleotides to the end of the molecule (poly(A) tail). Once this has been added, the cell is ruptured and its cell contents are exposed to synthetic beads that are coated with thymine string nucleotides. Because Adenine and Thymine pair together in DNA, the poly(A) tail and synthetic beads are attracted to one another, and once they bind in this process the cell components can be washed away without removing the mRNA. Once the mRNA has been isolated, reverse transcriptase is employed to convert it to single-stranded DNA, from which a stable double-stranded DNA is produced using DNA polymerase. Complementary DNA (cDNA) is much more stable than mRNA and so, once the double-stranded DNA has been produced it represents the expressed DNA sequence scientists look for.[4]

This technique is used to identify which genes or genetic mutations produce a certain phenotype. A mutagen is very often used to accelerate this process. Once mutants have been isolated, the mutated genes can be molecularly identified.

Forward saturation genetics is a method for treating organisms with a mutagen, then screens the organism's offspring for particular phenotypes. This type of genetic screening is used to find and identify all the genes involved in a trait.[5]

A mutation in a gene can cause encoded proteins and the cells that rely on those proteins to malfunction. Conditions related to gene mutations are called genetic disorders. However, altering a patient's genes can sometimes be used to treat or cure a disease as well. Gene therapy can be used to replace a mutated gene with the correct copy of the gene, to inactivate or knockout the expression of a malfunctioning gene, or to introduce a foreign gene to the body to help fight disease.[6] Major diseases that can be treated with gene therapy include viral infections, cancers, and inherited disorders, including immune system disorders.[7]

Gene therapy delivers a copy of the missing, mutated, or desired gene via a modified virus or vector to the patient's target cells so that a functional form of the protein can then be produced and incorporated into the body.[8] These vectors are often siRNA.[9] Treatment can be either in vivo or ex vivo. The therapy has to be repeated several times for the infected patient to continually be relieved, as repeated cell division and cell death slowly randomizes the body's ratio of functional-to-mutant genes. Gene therapy is an appealing alternative to some drug-based approaches, because gene therapy repairs the underlying genetic defect using the patients own cells with minimal side effects.[10] Gene therapies are still in development and mostly used in research settings. All experiments and products are controlled by the U.S. FDA and the NIH. [11][12]

Classical gene therapies usually require efficient transfer of cloned genes into the disease cells so that the introduced genes are expressed at sufficiently high levels to change the patient's physiology. There are several different physicochemical and biological methods that can be used to transfer genes into human cells. The size of the DNA fragments that can be transferred is very limited, and often the transferred gene is not a conventional gene. Horizontal gene transfer is the transfer of genetic material from one cell to another that is not its offspring. Artificial horizontal gene transfer is a form of genetic engineering.[13]

The Human Genome Project is a molecular genetics project that began in the 1990s and was projected to take fifteen years to complete. However, because of technological advances the progress of the project was advanced and the project finished in 2003, taking only thirteen years. The project was started by the U.S. Department of Energy and the National Institutes of Health in an effort to reach six set goals. These goals included:

The project was worked on by eighteen different countries including the United States, Japan, France, Germany, and the United Kingdom. The collaborative effort resulted in the discovery of the many benefits of molecular genetics. Discoveries such as molecular medicine, new energy sources and environmental applications, DNA forensics, and livestock breeding, are only a few of the benefits that molecular genetics can provide.[14]

NCBI: http://www.ncbi.nlm.nih.gov/About/primer/genetics_molecular.html

Here is the original post:
Molecular genetics - Wikipedia, the free encyclopedia

Posted in Molecular Genetics | Comments Off on Molecular genetics – Wikipedia, the free encyclopedia

Clinical Genetics Congress | Clinical Genetics 2016 …

Posted: September 28, 2016 at 5:47 pm

OMICS International welcomes all the attendees, speakers, sponsors and other research expertise from all over the world to theInternational conferenceon Clinical and Medical Genetics(Clinical Genetics 2016)which is going to be held duringNovember 28-29,2016inAtlanata, USA.We are very much honored to invite you all to exchange and share your views and experience on theCurrent Advancements and Novel Research on Clinical and Medical Genetics.

Clinical and medical geneticsare involved in the diagnosis and management ofhereditary disorderswhich determines the safety and effectiveness ofmedications,devices,diagnostic productsandtreatment regimenswhich are intended for human use and also be used for prevention, treatment, diagnosis or for relieving symptoms of a disease. There is a rapid growth in the field of Clinical and Molecular Genetics because of the increased prevalence ofinfectious diseases, causative mutating organisms which led to the discovery of novel clinical and genetic testing methods. TheGenetic testingmarket sale is estimated to reach $25 billion annually by 2021 with a growth rate of 10% in the United States. The genetic testing market is believed to reach approximately $60 billion by 2020 globally. US represent the largest market for genetic testing worldwide.

Track -1: Clinical Genetics:

Clinical Genetics is the medical specialty which provides adiagnostic serviceand"genetic counselling"for individuals or families with, or at risk of, conditions which may have a genetic basis. Genetic disorders can affect any body system and any age group. The aim of Genetic Services is tohelp those affected by, or at risk of, a genetic disorder to live and reproduce as normally as possible. Genetic disorders include :

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on Histocompatibility andImmunogenetics, November 28-30, 2016 San Antonio, USA; Conference on Genomics and Pharmacogenomics, September 12-14, 2016, Berlin, Germany; Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;Geneticsand Genomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage, Mutation and Cancer, March 13-18, 2016, Ventura, USA; Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA; Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track -2:Medical Genetics:

Medical geneticsis the branch ofmedicinethat involves the diagnosis and management ofhereditary disorders. Medical genetics differs fromhuman geneticsin that human genetics is a field of scientific research that may or may not apply to medicine, while medical genetics refers to the application of genetics to medical care. For example, research on the causes and inheritance ofgenetic disorderswould be considered within both human genetics and medical genetics, while the diagnosis, management, and counselling people with genetic disorders would be considered part of medical genetics.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on Histocompatibility andImmunogenetics, November 28-30, 2016 San Antonio, USA; Conference on Genomics and Pharmacogenomics, September 12-14, 2016, Berlin, Germany; Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;Geneticsand Genomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage, Mutation and Cancer, March 13-18, 2016, Ventura, USA; Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA; Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track -3:Mendelian Genetics: Past and the future

For thousands of years there were lot of questions aboutgeneticsand people followed different processes to produce hybrids of different plants and animals. But most of their trails failed as the actual mechanism behind it was unknown. ThereafterMendelwas the first to explain the concept of heredity after experimenting on pea plant (Pisum sativum)through his laws. He proposed Law of Segregation where only one allele pass from parent to offspring as the allele of parents gets separated ,Law of independent Assortment where different pairs of allele passes from parents independently, Law of Dominance where some alleles are dominant the remaining are recessive. Based on this, several hypotheses were proposed later.

Currently there are vast advancements in the field of genetics where researches are focusing on the different diseases caused by variations ingenesand many institutions are investing in the research. For example, US government, along with NIH funded Human Genome project based onDNA sequencingtechnologies. Due to the development of new techniques in Bioinformatics there is a huge decrease in the price of genome sequencing, from $100 million to $1000.

The involvement of genetics in heart diseases, cancer and other implications remained far from clear. There are possibilities of practicing human cloning, eugenics apart from these genetic advancements.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on Histocompatibility andImmunogenetics, November 28-30, 2016 San Antonio, USA; Conference on Genomics and Pharmacogenomics, September 12-14, 2016, Berlin, Germany; Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;Geneticsand Genomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage, Mutation and Cancer, March 13-18, 2016, Ventura, USA; Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA; Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track-4:Clinical Genomics

Clinical genomics is the use ofgenomic sequencingin clinical basis like for diagnosis, treatment of disease caused in patients. It is a new and rapidly changing field. The diseases like cystic fibrosis and sickle cell anaemia, which are caused by a single base pair change to DNA sequencing, these mutations can be corrected by CRISPR/ Cas technology.

Cas technologyis based ongenomeediting which is proposed by Editas Medicine with an investment of about $43million. Researchers adopted this technique as most of the microbes useproteinand RNAs against invading viruses. The technique involves the editing of stretches in DNA and also to edit single base pairs of the human genome. It was also believed to cure untreatable diseases possibly.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on HistocompatibilityandImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomicsand Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;GeneticsandGenomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage,Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA;Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track-5:Oncogenomics and Therapeutics

Oncogenomics is the study of the relationship between cancer and the genome of an individual. Its goal is to identifyoncogenesfor the diagnosis and treatment of cancer.Canceris a genetic disease as it is caused by genetic variation in DNA.NIH offers about $7.4 billion on research related to genetics and about $5.8 on cancer related research. The various techniques used are DNA sequencing,microarray, digital karyotyping, bacterial artificial chromosome.

The American Cancer Society reported that among 1.5 million cases half a million die from the disease mostly of breast cancer, lung cancer, bladder cancer, leukemia. The expenditure on cancer care in 2010 was $125 billion and is estimated to reach $156 billion by 2020 in US.US occupies seventh place inbreast cancerworldwide.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on HistocompatibilityandImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomicsand Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;GeneticsandGenomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage,Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA;Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track- 6:Clinical Epigenetics

Clinical epigeneticsuses the techniques involved in molecular biology to detect the alterations in DNA methylation or histone modification to diagnose disorders produced by heritable defects in thegene expression. DNA methylation involves in the addition of methyl groups to adenine and guanine bases. DNA is useful for cell development and when methylation occurs on CpG dinucleotide where cytosine precedes guanine suppresses the gene regulation. The nucleosome consists of historians where the tails of histone protrude from nucleosome and therefore they can be modified. The chemical groups attract activating or suppressing complexes to chromatin, which affects its shape, making it more or less available for gene expression. Epigenetic enzyme marketing consists of DNA-modifying, RNA-modifying, Protein is modifying Enzymes which is expected to reach a high rate by 2019. Bisulfite conversion kits; ChIP- seq kits; RNA sequencing kits; whole genome amplification kits are some of the epigenetic kits among which ChIP-seq kits segment had the biggest share in 2014.The market value ofepigeneticswas $413.24 million in 2014, it is expected to reach a CAGR of 13.64% from 2014 to 2019 and it is estimated to grow $783.17 million by 2019 globally.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain;Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK;conference on Histocompatibility andImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomics and Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;Geneticsand Genomics Conference,June 1-3, 2016, Nanjing, China;DNA Damage, Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulationin Development and Disease Conference,29 March 2016, Austin, USA;Maintenance ofGenome Stability2016,March 7-10, 2016, Panama, Central America.

Track-7:Regenerative Biology and Stem Cell Research

Regenerative biology involves the restoration or renewal of damaged genes, cells, tissues, organisms orecosystemthat is produced by some natural fluctuations.Regenerationis mediated by gene regulation and it may be complete (same as old tissue) or incomplete (fibrosis). The market value for tissue engineering and regeneration products was $55.9 billion in 2010 and $59.8 billion in 2011, and is expected to reach $89.7 billion by 2016 at a CAGR of 8.4% globally. According to the reports, the market value of regenerative medicine was about $2.5 billion in the US.

Stem cells are undifferentiated biological cells that undergo mitosis to produce more cells, which are found in multicellular organisms. They are of two types, embryonic and adult stem cells. The stem cell treatment was found to be a lifesaving treatment for the patients with solid tumors and blood disorders.Stem cellscan be obtained from the umbilical cord after babys birth. Possibly they can also be obtained from peripheral blood and bone marrow. According to the reports, in US the availability of stem cell therapy was $15.2 million in 2007 and $16.5 million in 2008 and it is estimated to reach $11 billion by 2020.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on HistocompatibilityandImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomicsand Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;GeneticsandGenomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage,Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA;Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track-8:Microbial and Human Genetics

There are millions ofmicroorganismsthat have a rapid impact on our health. They play a vital role in maintaining the health as well as in the onset of diseases.

Genomics applies DNA sequencing methods andBioinformaticsto analyze the structure and function of genomes. It started from bacteriophage but was overtaken by bacterial genomics. Its applications were included in the fields of medicine, biotechnology and social sciences.

Proteomics is the study of the structure and functions of proteins as they are the essential components of the various metabolic pathways of cells. It is more complicated when compared to genomic studies as it varies from cell to cell.Mass spectroscopyand microarray techniques are mostly used to study proteins presently.

The global market for DNA sequencing products and services in 2012 was $3.5 billion and $4.5 billion in 2013. It is expected to reach $11.7 billion by 2018 with a CAGR of 21.2%.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on HistocompatibilityandImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomicsand Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;GeneticsandGenomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage,Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA;Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track-9:Next Generation Sequencing

Next Generation Sequencingis a novel method for sequencing DNA and RNA more rapidly, which has made the study of genomics easy. It is the most versatile tool for medical and biological research. The techniques involved are Illumina sequencing, Roche 454 sequencing, Ion torrent: proton sequencing,Solid sequencing. Illumina sequencing is based on DNA colonies or clusters that involves in the clonal amplification of DNA on a surface.454 pyro sequencing amplifies DNA in side water droplets in an oily solution. Ion torrent sequencing is based on using sequencing chemistry with semiconductor based detection system. It is based on detection of hydrogen ions used during polymerisation of DNA whereas solid sequencing involves sequencing by ligation. The NGS market reached $231.7 million in 2012 and $510.7 million in 2013 and is expected to reach $7.6 billion by 2018 with a CAGR of 71.6% globally.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on HistocompatibilityandImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomicsand Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;GeneticsandGenomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage,Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA;Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America..

Track-10:Clinical Metabolics and Lipidomics

Lipids are the major components of biological membranes as well as the metabolites of organisms. Lipids play crucial role in biology. Imbalance in the lipid molecules leads to numerous diseases like atherosclerosis, obesity, diabetes, andAlzheimer's disease. Lipidomics is a system-based study of all lipids, which aims at the analysis of lipids in the biological system. Lipidomics is the main tool for potential biomarker discovery, diagnosis the disease and to understand disease pathology mainly in the fields of neurodegeneration, psychiatry, oncology, metabolic diseases, and infectious diseases. The global biomarkers market was $29.3 billion in 2013 and is expected to grow $53.6 billion in 2018 at a CAGR of 12.8%.

Clinical metabolomics is the major and the most powerful tool to screen metabolites in the biological samples. These provide predictive and prognostic biomarkers which are useful to monitor disease states and to improve therapeutic levels. Discovery of biomarkers to differentiate diseases at molecular levels is a difficult task as the metabolite profile is related to the phenotype of an organism;metabolomicsprovide a better understanding of systemic diseases. Metabolomics is also practiced in crop breeding, toxicology, plant biotechnology. The market value formetabolomicswas $712 million in 2012 and is expected to reach nearly $1.4 billion in 2017 at a CAGR of 14.2% globally.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain;Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK;conference on Histocompatibility andImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomics and Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;Geneticsand Genomics Conference,June 1-3, 2016, Nanjing, China;DNA Damage, Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulationin Development and Disease Conference,29 March 2016, Austin, USA;Maintenance ofGenome Stability2016,March 7-10, 2016, Panama, Central America.

Track-11:Medical and Developmental Genetics

Right from the zygote to a developed individual every process is regulated by genes.Developmental geneticsis concerned with the process in which genes regulate the development. It is the study of cell fate, cell determination and embryonic development. There are many theories proposed and among them differential gene expression is the most accepted one. The ability to produce an organism from cells is called totipotent, unipotent stem cells produce a family of related cells. Pluripotent and multipoint produce only few organs or tissues, but all these cells forms, acell lineagewhose differentiation can be done by a master control gene. Likewise immune cells are produced from bone marrow; B-cells are responsible for antibody production. By Invivo production of B-cells, antibody diversity can be achieved as process follows differential gene expression. The prenatal and newborngenetic testingmarket were $1.12 billionin 2012 and expected to grow $8.37 billionin 2019 at a CAGR of 26.9% from 2013 to 2019 globally.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on HistocompatibilityandImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomicsand Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;GeneticsandGenomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage,Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA;Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track-12: Genetic Medicine

Genetic medicineis the integration and application of genomic technologies allows biomedical researchers and clinicians to collect data from large study population and to understand disease and genetic bases of drug response. It includes genome structure, functional genomics,epigenomics,genome scale population genomics, systems analysis, pharmacogenomics and proteomics. The Division of Genetic Medicine provides an academic environment enabling researchers to explore new relationships between disease susceptibility and human genetics. The Division of Genetic Medicine was established to host both research and clinical research programs focused on the genetic basis of health and disease. Equipped with state-of-the-art research tools and facilities, our faculty members are advancing knowledge of the common genetic determinants of cancer, congenital neuropathies, and heart disease.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on HistocompatibilityandImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomicsand Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;GeneticsandGenomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage,Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA;Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track-13:GeneticProbe

A section ofDNAof known structure or function which is marked with aradioactive isotope, dye or enzyme so that it can be used to detect the presence of specific sequences of bases in another DNA or RNA molecule.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on HistocompatibilityandImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomicsand Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;GeneticsandGenomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage,Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA;Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track-14:Genetic Linkage Analysis

Geneticlinkage analysis is a statistical method that is used to associate functionality of genes to their location onchromosomes. Neighboring genes on the chromosome have a tendency to stick together when passed on to offsprings. Therefore, if some disease is often passed to offsprings along with specific marker-genes , then it can be concluded that the gene(s) which are responsible for the disease are located close on the chromosome to these markers.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on HistocompatibilityandImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomicsand Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;GeneticsandGenomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage,Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA;Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track-15:Genetic Testing for Diseases

This is the analysis of chromosomes, proteins, and metabolites.Genetic testing for diseasescan provide important information for diagnosing, treating and preventing illness. Genetic testing identifies the changes in chromosomes, genes, or proteins. These are performed on a sample of blood, hair, skin, amniotic fluid, or other tissue.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on HistocompatibilityandImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomicsand Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;GeneticsandGenomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage,Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA;Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track-16:Genetic Syndromes and Related Disorders

Genetic disorder is a genetic problem which is associated with the abnormalities in the genome, it may or may not be heritable. For example, cancer can be caused by some inherited genes or by newmutationsor it may be environmental cause in some patients. There are many genetic disorders among them Single-gene disorder is the one which is the resultant of a single mutated gene. It includes diseases like Cystic fibrosis,Sickle-cell-anemia, Polycystic kidney disease, Hemophilia-A, Albinism. Multifactorial diseases include diabetes and heart diseases. Most of the genetic disorders can be identified at birth or in childhood like Huntingtons disease. Treatment for these genetic disorders is still a battle where around 1800 clinical trials have been completed. Presently Gene therapy is followed in which a new gene is introduced to a patient which is very complicated. The market value of products to treatgenetic disorderswas $12.8 billion in 2009 and $17.3 in 2014 globally.

The market value for cancer treatment was about $51.2 billion in 2014 and is expected to reach $66.4 billion by 2019, with a CAGR of 5.4% from 2014 to 2019 globally.The autism spectrum disorders(ASD) market was about $346.2 million in 2013 and $360.9 million in 2014. The market value is expected to grow to $412.7 million by 2019, with a CAGR of 2.7 %.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on HistocompatibilityandImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomicsand Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;GeneticsandGenomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage,Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA;Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track-17:Genetics Market:

While the evidence base is still growing, genetic services industry leaders strongly believe that emerging testing capabilities will have significant clinical impact in the future. Many expressed opinions that genetic services will make significant contributions to prediction, detection, and care selection, leading to better quality care and increased affordability. Available genetic tests and genomic applications, can be categorized according to their clinical method of use across prediction, detection, and care selection. The prenatal and newborngenetic testingmarket were $1.12 billionin 2012 and expected to grow $8.37 billionin 2019 at a CAGR of 26.9% from 2013 to 2019 globally.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on HistocompatibilityandImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomicsand Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;GeneticsandGenomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage,Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA;Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Track-18: Genetic Testing for Inherited Cardiac Disease

Over the past 2 decades, investigators in the field of cardiac genetics have evolved a complex understanding of the pathophysiological basis of inherited cardiac diseases, which predispose individuals to sudden cardiac death. In this Review, we describe the current status of gene discovery and the associations between phenotype and genotype in the cardiac channelopathies and cardiomyopathies. The various indications for genetic testing and its utility in the clinic are assessed in relation to diagnosis, cascade testing, guiding management, and prognosis. Some common problems exist across all phenotypes: the variable penetrance and expressivity of genetic disease, and the difficulty of assessing the functional and clinical effects of novel mutations. These issues will be of particular importance as the next-generation sequencing technologies are used by genetics laboratories to provide results from large panels of genes. The accurate interpretation of these results will be the main challenge for the future.

Related Conferences:

World congress onHuman Genetics, October 31 - November 02, 2016 Valencia, Spain; Conference on Genetics Counseling andGenomicsMedicine, Aug 11-12, 2016 Birmingham, UK; Conference on HistocompatibilityandImmunogenetics, November 28-30, 2016 San Antonio, USA;Conference on Genomicsand Pharmacogenomics, September 12-14, 2016, Berlin, Germany;Conference onCancer Genomics, Aug 8-9, 2016 Las Vegas, USA;GeneticsandGenomics Conference, June 1-3, 2016, Nanjing, China;DNA Damage,Mutation and Cancer,March 13-18, 2016, Ventura, USA;Chromatin andEpigenetics, 20 March 2016, Dubrovnik, Croatia; Chromatin,Non-coding RNAsand RNAP II Regulation in Development and Disease Conference, 29 March 2016, Austin, USA;Maintenance ofGenome Stability2016, March 7-10, 2016, Panama, Central America.

Cell Therapy-2015

OMICS International Conferencessuccessfully hosted its premier4thInternational Conference and Exhibition on Cell & Gene Therapyduring August 10-12, 2015 at Crowne Plaza London-Heathrow, London, United Kingdom.

The conference brought together a comprehensive range of the cell and gene therapy researchers, educators from research universities as well as representatives from industry and professional cell and gene therapy societies.

Cell Therapy-2015is known for uplifting the future of cell and gene therapy and its allied areas by encouraging students and fellow researchers to present their work through poster presentations and young research forum. Students participated with great zeal and the best posters were awarded for their efforts and outstanding contribution to the cell and gene therapy research.

OMICS InternationalConferenceswishes to acknowledge with its deep sincere gratitude to all the supporters from the Editorial Board Members of our Open Access Journals, Keynote speakers, Honorable guests, valuable speakers, poster presenters, students, delegates and special thanks to the media partnersfor their promotion to make this event a huge success.

This4thInternational Conference and Exhibition on Cell & Gene Therapybased on the themeGenomic therapies from base pairs to bedsidewhich covered the below scientific sessions like Cell and Gene Therapy: Potential Applications, Plant Stem Cell Rejuvenation, Plant Stem Cells: Human Therapeutics, Stem Cell Therapies, Cellular Therapies, Advanced Gene Therapeutics, Molecular basis of epigenetics, Cancer Therapies, Nano-Therapy, Bioengineering Therapeutics, Clinical Trials and Research in Cell and Gene Therapies, Regulatory and Ethical Issues of Therapies.

The conference was greeted by the conference Moderator:Dr. Andrei Laikhter,Chemgenes Corporation, USA. The support was extended by the Keynote Speaker:Dr. James Koropatnic,Lawson Health Research Institute and Western University;Dr. Anelia Atanassova,BioGlobaX Inc., Canada;Dr. Noriyuki Kasahara,University of Miami, USA;Dr. Robert Hawkins,The Christie Hospital and University of Manchester, UK andDr. Paul L. Hermonat, Central Arkansas Veterans Healthcare System, USA

OMICSInternationalacknowledges the support of below Chairs and Co-chairs with whom we were able to run the scientific sessions smoothly it included:Dr. Ajan Reginald,Cell Therapy Limited, UK;Dr. Andrei Laikhter,Chemgenes Corporation, USA;Dr. Vasiliki Kalodimou,IASO Maternity Hospital, Greece;Dr. Geeta Shroff,Nutech Medicworld, India;Dr. Nady Golestaneh,Georgetown University School of Medicine, USA;Dr. James Koropatnick,Lawson Health Research Institute and Western University, Canada;Dr. Robert Hawkins,Christie Hospital and University of Manchester, UK.

This4thInternational Conference and Exhibition on Cell & Gene Therapywas uplifted with more than 32 oral presentations by researchers, scientists, professors, industry delegates and more than 15 poster participants around the globe. OMICS International has taken the privilege of felicitating Cell Therapy-2015 Organizing Committee Members, Editorial Board Members of the supported Journals and Keynote Speakers who supported for the success of this event.

With the enormous feedback from the participants and supporters 4thInternational Conference and Exhibition on Cell & Gene Therapy,OMICS International Conferencesis glad to announce its5thInternational Conference and Exhibition on Cell & Gene Therapy(Cell Therapy-2016) event from May 19-21, 2016 at San Antonio, USA

- See more at: http://cellgenetherapy.conferenceseries.com/#sthash.npJGo7Qv.dpuf

OMICS International Conferencessuccessfully hosted its premier4thInternational Conference and Exhibition on Cell & Gene Therapyduring August 10-12, 2015 at Crowne Plaza London-Heathrow, London, United Kingdom.

The conference brought together a comprehensive range of the cell and gene therapy researchers, educators from research universities as well as representatives from industry and professional cell and gene therapy societies.

Cell Therapy-2015is known for uplifting the future of cell and gene therapy and its allied areas by encouraging students and fellow researchers to present their work through poster presentations and young research forum. Students participated with great zeal and the best posters were awarded for their efforts and outstanding contribution to the cell and gene therapy research.

OMICS InternationalConferenceswishes to acknowledge with its deep sincere gratitude to all the supporters from the Editorial Board Members of our Open Access Journals, Keynote speakers, Honorable guests, valuable speakers, poster presenters, students, delegates and special thanks to the media partnersfor their promotion to make this event a huge success.

More here:
Clinical Genetics Congress | Clinical Genetics 2016 ...

Posted in Molecular Genetics | Comments Off on Clinical Genetics Congress | Clinical Genetics 2016 …

Integrative Medicine – San Diego – Scripps Health

Posted: September 28, 2016 at 5:46 pm

Scripps Center for Integrative Medicine in San Diego

The Scripps Center for Integrative Medicine offers the best of conventional and complementary medicine. We believe there are many paths to healing and that holistic health is a cohesive balance of mind, body and spirit. Through clinical research, patient education and the design of healing medicine programs combined with preventive health. Our experts blend evidence-based complementary and alternative therapies with conventional Western medicine in a best of both worlds approach to treating disease, healing and improving health.

Sign up for Empowering Health and Healing, a free quarterly newsletter designed to keep your mind, body and spirit healthy.

At Scripps Center for Integrative Medicine, we take a whole person approach to health and wellness. We believe that health is dynamic, continually influenced by how we live our lives and how we relate to the world around us. And, we believe that healing starts from within.

Because there is no magic pill for health and well-being, the road to healing requires a diverse, collaborative team of integrative medicine professionals dedicated to treating mind, body and spirit.

From physicians and nurses trained at the countrys most prestigious medical centers to our full spectrum of licensed and certified practitioners in allopathic and alternative medicine, the centers specialists are at the forefront of integrative medicine.

We care for people with cancer, diabetes, stress, womens health issues, and many other health concerns.

We empower you to promote your own healing with a full range of conventional and complementary treatments and therapies. Through clinical research, education, prevention, and lifestyle changes, youll discover powerful new ways to take control of your health.

Continue reading here:
Integrative Medicine - San Diego - Scripps Health

Posted in Integrative Medicine | Comments Off on Integrative Medicine – San Diego – Scripps Health

UC Davis Integrative Medicine – Official Blog

Posted: September 28, 2016 at 5:46 pm

By Rosane Oliveira on September 21, 2016September 28, 2016

This is the eighth article in our Controversies series and the fourth on the subject of fats.

Obesity. (more)

By Rosane Oliveira on September 18, 2016September 18, 2016

As members of a whole food, plant-based community, we all understand just how much perseverance and dedication it can sometimes take to follow a plant-based diet.

It requires educating ourselves, planning, organizing, and being creative. (more)

By Rosane Oliveira on September 14, 2016September 22, 2016

This is the seventh article in our Controversies series and the third piece focusing on the subject of fats. (more)

By Rosane Oliveira on September 11, 2016September 16, 2016

George Washington Carver, a researcher from Iowa State University, once discovered over 300 uses for the humble peanut, including 105 recipes.

He raised the peanuts profile from a simple legume to a powerful tool for crop (more)

By Rosane Oliveira on September 7, 2016September 16, 2016

This is the sixth in our Controversies series and the second article regarding the subject of fats.

By Rosane Oliveira on September 4, 2016September 3, 2016

We are here today to praiseNational Acorn Squash Day, celebrated on September 7th.

The holiday honors the contribution that this humble, somewhat mysterious, and often overlooked plant has made to the human diet. (more)

By Rosane Oliveira on August 31, 2016September 16, 2016

In this fifth installment of our Controversies series, we are going to explore the topic of trans fats. (more)

By Rosane Oliveira on August 28, 2016September 16, 2016

When was the last time you sat down to write an actual handwritten letter? (more)

By Rosane Oliveira on August 24, 2016August 24, 2016

This article, which focuses on how and when to follow a gluten-free diet, is the fourth in our Controversies series.

Given the relentless gluten-free craze out there, millions of people are asking themselves two questions: (more)

Original post:
UC Davis Integrative Medicine - Official Blog

Posted in Integrative Medicine | Comments Off on UC Davis Integrative Medicine – Official Blog

Page 1,704«..1020..1,7031,7041,7051,706..1,7101,720..»